Alnylam Pharmaceuticals 2022 Q4 Earnings Financial Results

Alnylam Pharmaceuticals presents its fourth quarter and full year 2022 financial results, featuring commercial highlights for its approved RNAi therapeutics and pipeline updates. The presentation outlines progress on the company's P5x25 strategy and financial performance with discussions on commercial expansion and upcoming milestones.